Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective studyHouli Zhao, Yongxian Hu, Didier Blaise et al.|Journal of Hematology & Oncology|2020Cited by 82
CD19 Chimeric Antigen Receptor T-cell Shows Activity in Patients with B-cell Lymphoma Without CD19 Expression by ImmunohistochemistryTao Wang, Jian-Min Yang|Research Square|2021Cited by 0